MÁJEK, Ondřej, Marek BABJUK, Monique J ROOBOL, Ola BRATT, Van Poppel HENDRIK, Roman ZACHOVAL, Jiri FERDA, Marcela KOUDELKOVÁ, Ondřej NGO, Jakub GREGOR, Sarah COLLEN, Karel HEJDUK, Ladislav DUŠEK and Vlastimil VÁLEK. How to follow the new EU Council recommendation and improve prostate cancer early detection: the Prostaforum 2022 declaration. EUROPEAN UROLOGY OPEN SCIENCE. AMSTERDAM: ELSEVIER, 2023, vol. 53, July 2023, p. 106-108. ISSN 2666-1691. Available from: https://dx.doi.org/10.1016/j.euros.2023.05.011.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name How to follow the new EU Council recommendation and improve prostate cancer early detection: the Prostaforum 2022 declaration
Authors MÁJEK, Ondřej (203 Czech Republic, belonging to the institution), Marek BABJUK (203 Czech Republic), Monique J ROOBOL, Ola BRATT, Van Poppel HENDRIK, Roman ZACHOVAL (203 Czech Republic), Jiri FERDA (203 Czech Republic), Marcela KOUDELKOVÁ (203 Czech Republic, belonging to the institution), Ondřej NGO (203 Czech Republic, belonging to the institution), Jakub GREGOR (203 Czech Republic, belonging to the institution), Sarah COLLEN, Karel HEJDUK (203 Czech Republic, belonging to the institution), Ladislav DUŠEK (203 Czech Republic, belonging to the institution) and Vlastimil VÁLEK (203 Czech Republic, belonging to the institution).
Edition EUROPEAN UROLOGY OPEN SCIENCE, AMSTERDAM, ELSEVIER, 2023, 2666-1691.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30217 Urology and nephrology
Country of publisher Netherlands
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 2.500 in 2022
RIV identification code RIV/00216224:14110/23:00133367
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1016/j.euros.2023.05.011
UT WoS 001055274700001
Keywords in English Cancer screening; Pilot studies; Prostate cancer
Tags 14110216, 14119612, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 1/2/2024 10:10.
Abstract
An updated Council of the EU recommendation on cancer screening was adopted in December 2022 during the Czech EU presidency. The recommendation included prostate cancer as a suitable target disease for organised screening, and invited countries to proceed with piloting and further research. To support further discussions and actions to promote early detection of prostate cancer, an international conference in November 2022 (Prostaforum 2022) resulted in a joint declaration. Here we describe the EU policy background, summarise the preparation of the declaration and the key underlying evidence and expert recommendations, and report the text of the declaration. The declaration summarises the striking inequalities in prostate cancer burden in Europe and calls on all stakeholders to consider and support concrete steps for advancement of organised early detection of prostate cancer. Our aim is to request endorsement of the text and potential initiation of practical actions by all stakeholders to support the aims of the declaration.Patient summary: Prostate cancer is among the most frequent cancers and is one of the most common causes of cancer death among men. The European Union has recommended new pilot programmes for prostate cancer screening. The Prostaforum 2022 declaration invites all stakeholders to support this new recommendation with specific steps.& COPY; 2023 The Author(s). Published by Elsevier B.V. on behalf of European Association of Urology. This is an open access article under the CC BY license (http://creativecommons. org/licenses/by/4.0/).
PrintDisplayed: 24/7/2024 12:26